A fourth federal judge upholds the program, one of President Joe Biden's signature initiatives, against drug industry challenges, rejecting their argument that it was an illegal taking of their property.
The state Prescription Drug Affordability Board has drawn passionate opposition from patients with rare diseases who worry that the board’s actions could have unintended consequences.
Mark Cuban has a straightforward question for the drug middleman owned by CVS: If you're as transparent about drug pricing as you claim, why don't you publish prices on your website?
The maker of Tylenol, Listerine, Neutrogena, Band-Aids and Benadryl plans a global headquarters in New Jersey with over 3,000 scientists and other employees over the next few years.
The New Jersey-based drugmaker said it expected annual earnings of $8.53 to $8.65 per share, up from its previous forecast of $8.44 to $8.59. Analysts had estimated earnings of $8.56 per share.